Effective mosaic-based nanovaccines against avian influenza in poultry |
| |
| Institution: | 1. Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA;2. Pan Genome Systems, Madison, WI, USA;3. Department of Chemical and Biological Engineering, Iowa State University, Ames, IA, USA;1. Medigen, Inc., 8420 Gas House Pike, Suite S, Frederick, MD, USA;2. Wuhan Siqiyuan Ltd., 666 Gaoxin Road, Wuhan, China;3. Viral Pathogenesis and Evolution Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 33 North Drive, Bethesda, MD, USA;4. Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road N.E., Atlanta, GA, USA;1. Food Animal Health Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, OH, United States;2. Department of Veterinary Preventive Medicine, College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States;3. Division of Infectious Diseases, Cincinnati Children''s Hospital Medical Center, Cincinnati, OH, United States;4. Poultry Diseases Department, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt;1. Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan, Shandong, China;2. Shandong Key Lab of Animal Disease Control and Breeding, Jinan, Shandong, China;3. College of Animal Science, Shandong Agricultural University, Tai’an, Shandong, China;4. Department of Pathobiology and Veterinary Science, University of Connecticut, Storrs, CT, USA;1. Immunology Department, Animal Health Research Institute, Dokki, Giza, Egypt;2. Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute, Dokki, Giza, Egypt;3. Biotechnology Department, Animal Health Research Institute, Dokki, Giza, Egypt;4. Central Laboratory for Evaluation of Veterinary Biologics (CLEVB), Abbassia, Cairo, Egypt;5. Analysis & Evaluation Department, Egyptian Petroleum Research Institute, 11727, Cairo, Egypt |
| |
| Abstract: | Avian influenza virus (AIV) is an extraordinarily diverse pathogen that causes significant morbidity in domesticated poultry populations and threatens human life with looming pandemic potential. Controlling avian influenza in susceptible populations requires highly effective, economical and broadly reactive vaccines. Several AIV vaccines have proven insufficient despite their wide use, and better technologies are needed to improve their immunogenicity and broaden effectiveness. Previously, we developed a “mosaic” H5 subtype hemagglutinin (HA) AIV vaccine and demonstrated its broad protection against diverse highly pathogenic H5N1 and seasonal H1N1 virus strains in mouse and non-human primate models. There is a significant interest in developing effective and safe vaccines against AIV that cannot contribute to the emergence of new strains of the virus once circulating in poultry. Here, we report on the development of an H5 mosaic (H5M) vaccine antigen formulated with polyanhydride nanoparticles (PAN) that provide sustained release of encapsulated antigens. H5M vaccine constructs were immunogenic whether delivered by the modified virus Ankara (MVA) strain or encapsulated within PAN. Both humoral and cellular immune responses were generated in both specific-pathogen free (SPF) and commercial chicks. Importantly, chicks vaccinated by H5M constructs were protected in terms of viral shedding from divergent challenge with a low pathogenicity avian influenza (LPAI) strain at 8 weeks post-vaccination. In addition, protective levels of humoral immunity were generated against highly pathogenic avian influenza (HPAI) of the similar H5N1 and genetically dissimilar H5N2 viruses. Overall, the developed platform technologies (MVA vector and PAN encapsulation) were safe and provided high levels of sustained protection against AIV in chickens. Such approaches could be used to design more efficacious vaccines against other important poultry infections. |
| |
| Keywords: | Nanoparticle vaccine Modified vaccinia Ankara Avian influenza Vaccine vector |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
